Quantifying human IFN-β using an HTRF-based approach
This note demonstrates how using HTRF to quantify human IFN-β is a powerful and effective method for the characterization of STING agonists.
It provides data demonstrating that the quantification of IFN-β using HTRF is well correlated with ELISA assays.
This note also provides data about gene reporter assay correlation with our HTRF IFN-β assay.
